BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32424971)

  • 1. Mu opioid receptor knockout mouse: Phenotypes with implications on restless legs syndrome.
    Lyu S; DeAndrade MP; Unger EL; Mueller S; Oksche A; Walters AS; Li Y
    J Neurosci Res; 2020 Aug; 98(8):1532-1548. PubMed ID: 32424971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperactivity, dopaminergic abnormalities, iron deficiency and anemia in an in vivo opioid receptors knockout mouse: Implications for the restless legs syndrome.
    Lyu S; DeAndrade MP; Mueller S; Oksche A; Walters AS; Li Y
    Behav Brain Res; 2019 Nov; 374():112123. PubMed ID: 31376441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of the role of the endogenous opioid and melanocortin systems in the restless legs syndrome.
    Walters AS; Li Y; Koo BB; Ondo WG; Weinstock LB; Champion D; Afrin LB; Karroum EG; Bagai K; Spruyt K
    Brain; 2024 Jan; 147(1):26-38. PubMed ID: 37633259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor restlessness, sleep disturbances, thermal sensory alterations and elevated serum iron levels in Btbd9 mutant mice.
    DeAndrade MP; Johnson RL; Unger EL; Zhang L; van Groen T; Gamble KL; Li Y
    Hum Mol Genet; 2012 Sep; 21(18):3984-92. PubMed ID: 22678064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the role of the endogenous opiate system in the pathogenesis of anemia in an opiate receptor knock-out model of Restless Legs Syndrome.
    Walters AS; Li Y; Karroum EG; Champion D; Weinstock LB; Bagai K; Afrin LB; Spruyt K
    Med Hypotheses; 2022 Oct; 167():. PubMed ID: 36505961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine receptors as markers of brain iron deficiency: Implications for Restless Legs Syndrome.
    Quiroz C; Gulyani S; Ruiqian W; Bonaventura J; Cutler R; Pearson V; Allen RP; Earley CJ; Mattson MP; Ferré S
    Neuropharmacology; 2016 Dec; 111():160-168. PubMed ID: 27600688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D3 receptor specifically modulates motor and sensory symptoms in iron-deficient mice.
    Dowling P; Klinker F; Stadelmann C; Hasan K; Paulus W; Liebetanz D
    J Neurosci; 2011 Jan; 31(1):70-7. PubMed ID: 21209191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome.
    Khan FH; Ahlberg CD; Chow CA; Shah DR; Koo BB
    J Neurol; 2017 Aug; 264(8):1634-1641. PubMed ID: 28236139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiology of restless legs syndrome].
    Miyamoto M; Miyamoto T; Iwanami M; Suzuki K; Hirata K
    Brain Nerve; 2009 May; 61(5):523-32. PubMed ID: 19514512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron.
    Lee KA; Zaffke ME; Baratte-Beebe K
    J Womens Health Gend Based Med; 2001 May; 10(4):335-41. PubMed ID: 11445024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of BTBD9 in Striatum and Restless Legs Syndrome.
    Lyu S; Xing H; DeAndrade MP; Liu Y; Perez PD; Yokoi F; Febo M; Walters AS; Li Y
    eNeuro; 2019; 6(5):. PubMed ID: 31444227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of Meis1, a transcriptional regulator, in mice and worms: Neurochemical and behavioral characterizations with implications in the restless legs syndrome.
    Lyu S; Xing H; Liu Y; Girdhar P; Zhang K; Yokoi F; Xiao R; Li Y
    J Neurochem; 2020 Dec; 155(5):522-537. PubMed ID: 32910473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restless legs syndrome and iron deficiency in adults with attention-deficit/hyperactivity disorder.
    Lopez R; Micoulaud Franchi JA; Chenini S; Gachet M; Jaussent I; Dauvilliers Y
    Sleep; 2019 May; 42(5):. PubMed ID: 30722056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between low serum ferritin and restless legs syndrome in patients with attention deficit hyperactivity disorder.
    Oner P; Dirik EB; Taner Y; Caykoylu A; Anlar O
    Tohoku J Exp Med; 2007 Nov; 213(3):269-76. PubMed ID: 17984624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Restless-legs syndrome].
    Karroum E; Konofal E; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):701-21. PubMed ID: 18656214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron-deficiency and dopaminergic treatment effects on RLS-Like behaviors of an animal model with the brain iron deficiency pattern of the restless legs syndrome.
    Allen RP; Earley CJ; Jones BC; Unger EL
    Sleep Med; 2020 Jul; 71():141-148. PubMed ID: 32094092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restless legs syndrome: pathophysiology and the role of iron and folate.
    Patrick LR
    Altern Med Rev; 2007 Jun; 12(2):101-12. PubMed ID: 17604457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Restless legs syndrome in patients with high serum ferritin and normal iron levels].
    Peraita-Adrados R; Duque-Ramírez LG; Vela-Bueno A
    Rev Neurol; 2011 Oct; 53(7):385-9. PubMed ID: 21948008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective.
    Clemens S; Rye D; Hochman S
    Neurology; 2006 Jul; 67(1):125-30. PubMed ID: 16832090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BTBD9 and dopaminergic dysfunction in the pathogenesis of restless legs syndrome.
    Lyu S; Doroodchi A; Xing H; Sheng Y; DeAndrade MP; Yang Y; Johnson TL; Clemens S; Yokoi F; Miller MA; Xiao R; Li Y
    Brain Struct Funct; 2020 Jul; 225(6):1743-1760. PubMed ID: 32468214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.